Intrauterine Devices Global Market Report 2026

Intrauterine devices are small, T-shaped contraceptive devices inserted into the uterus to prevent pregnancy. These devices offer a highly effective and long-lasting method of birth control. Their mechanism involves altering the uterine environment to make it less favorable for sperm to fertilize an egg and, in some cases, affecting the uterine lining to inhibit implantation.

The main types of intrauterine devices include hormonal intrauterine devices and copper intrauterine devices. Hormonal intrauterine devices, often referred to as hormonal IUDs, are contraceptive devices inserted into the uterus for pregnancy prevention. These devices cater to various age groups, such as 15-24 years, 25-34 years, 35-44 years, and those above 44 years. End users of these devices include hospitals, gynecology clinics, community healthcare, and others.

Tariffs are influencing the intrauterine devices market by increasing costs of imported medical-grade plastics, copper components, hormonal reservoirs, and precision manufacturing tools used in IUD production. Healthcare providers in North America and Europe are most affected due to reliance on imported devices, while Asia-Pacific faces pricing pressures in export-oriented manufacturing. These tariffs are contributing to higher device costs and procurement delays. At the same time, they are encouraging domestic production, regional manufacturing expansion, and supply chain localization for contraceptive devices.

The intrauterine devices market research report is one of a series of new reports from The Business Research Company that provides intrauterine devices market statistics, including intrauterine devices industry global market size, regional shares, competitors with a intrauterine devices market share, detailed intrauterine devices market segments, market trends and opportunities, and any further data you may need to thrive in the intrauterine devices industry. This intrauterine devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intrauterine devices market size has grown steadily in recent years. It will grow from $4.14 billion in 2025 to $4.31 billion in 2026 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing awareness of family planning options, expansion of women's healthcare services, growing acceptance of long-term contraception, availability of affordable contraceptive devices, rising focus on reproductive health.

The intrauterine devices market size is expected to see steady growth in the next few years. It will grow to $5.08 billion in 2030 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to increasing demand for low-maintenance contraceptive solutions, expansion of public health family planning programs, growing preference for hormone-regulated devices, increasing adoption across emerging economies, ongoing innovation in iud materials and designs. Major trends in the forecast period include increasing adoption of long-acting contraceptive devices, rising demand for hormonal iuds, growing preference for reversible birth control methods, expansion of copper-based non-hormonal options, enhanced focus on patient safety and comfort.

The growing participation of women in the workforce is expected to drive the expansion of the intrauterine devices market in the coming years. Women in the workforce refers to the involvement and representation of women in paid employment across a wide range of industries and occupations. The rise in female workforce participation is fueled by increased economic independence, as more women pursue professional careers, contribute to household income, and generate greater demand for healthcare solutions. Intrauterine devices provide working women with a convenient, low-maintenance, and highly effective contraceptive method, offering long-term prevention of unintended pregnancies. For example, in April 2025, according to the National Association of Home Builders, a US-based trade organization, as of March 2025, workforce participation remained steady at 57.5%, with women making up nearly 47% of the total U.S. workforce. Therefore, the increasing number of women in the workforce is contributing to the growth of the intrauterine devices market.

Major companies operating in the intrauterine devices (IUD) market are emphasizing product innovation, including single-hand IUD insertion delivery systems, to simplify device placement, improve clinician ergonomics, and increase procedural efficiency while maintaining contraceptive effectiveness. Single-hand IUD insertion delivery systems incorporate an integrated loading mechanism and streamlined deployment controls, allowing healthcare providers to perform insertions with greater accuracy, fewer procedural steps, and enhanced ease of use in high-volume clinical environments. For example, in September 2024, CooperSurgical, a US-based women's health and medical device company, introduced an FDA-approved single-hand inserter for the Paragard intrauterine copper contraceptive. The updated inserter includes a user-friendly, one-hand operation with an integrated loading tip that facilitates smoother placement while preserving Paragard's proven advantages of more than 99% effectiveness, a 10-year lifespan, hormone-free contraception, and immediate reversibility.

In November 2023, Bayer AG, a Germany-based life sciences and pharmaceutical company, entered into a development and option-to-license agreement with CrossBay Medical Inc. for an undisclosed sum. Through this collaboration, Bayer seeks to develop and commercialize a next-generation single-handed intrauterine system (IUS) inserter by incorporating CrossGlide technology to enhance insertion comfort, shorten procedure duration, and improve the overall IUS placement experience. CrossBay Medical Inc. is a US-based medical device company focused on developing innovative technologies for intrauterine device insertion.

Major companies operating in the intrauterine devices market are Bayer AG, CooperSurgical Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Pregna International Limited, Medicines360 Inc, Eurogine S L, SMB Corporation, HLL Lifecare Limited, Injeflex Industria E Commercio Ltd, Corporate Channels India Pvt Ltd, Meril Endo Surgery Pvt Ltd, Krishco Medical Products Pvt Ltd, Prosan International BV, Gima Spa, Laboratoire HRA Pharma SAS, Shandong Weigao Medical Group Co Ltd, Chongqing Zhifei Biological Products Co Ltd, Yantai JiShengYaoXie Co Ltd, TianYi (China based IUD maker), Sebela Pharmaceuticals Inc, Fuji Latex Co Ltd

North America was the largest region in the intrauterine devices market in 2025. The regions covered in the intrauterine devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intrauterine devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The intrauterine device market consists of sales of T-shaped frames, frameless IUDs, insertion devices, IUD removal kits, and monofilament strings. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intrauterine Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses intrauterine devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intrauterine devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intrauterine devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Hormonal Intrauterine Device; Copper Intrauterine Device
• 2) By Age Group: 15-24 Years; 25-34 Years; 35-44 Years; Above 44 Years
• 3) By End-User: Hospitals; Gynecology Clinics; Community Healthcare; Other End Users
• Subsegments:
• 1) By Hormonal Intrauterine Device: Levonorgestrel-Releasing IUD (e.g., Mirena, Kyleena, Skyla); Progestin-Based IUD
• 2) By Copper Intrauterine Device: Standard Copper IUD; Mini Copper IUD
• Companies Mentioned: Bayer AG; CooperSurgical Inc; Merck & Co Inc; Teva Pharmaceutical Industries Ltd; Pregna International Limited; Medicines360 Inc; Eurogine S L; SMB Corporation; HLL Lifecare Limited; Injeflex Industria E Commercio Ltd; Corporate Channels India Pvt Ltd; Meril Endo Surgery Pvt Ltd; Krishco Medical Products Pvt Ltd; Prosan International BV; Gima Spa; Laboratoire HRA Pharma SAS; Shandong Weigao Medical Group Co Ltd; Chongqing Zhifei Biological Products Co Ltd; Yantai JiShengYaoXie Co Ltd; TianYi (China based IUD maker); Sebela Pharmaceuticals Inc; Fuji Latex Co Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.